The primary endpoint for phase D was time to treatment failure. The study met its primary endpoint in phase A, with a mean pain reduction of −1.9 NRS …
Source: lower back pain relief
Chronic low back pain (CLBP) affects over half a billion people worldwide. Current pharmacologic treatments offer limited efficacy and carry …
Source: back pain
The primary endpoint for phase D was time to treatment failure. The study met its primary endpoint in phase A, with a mean pain reduction of −1.9 NRS …
Source: pain medication
WASHINGTON — An experimental medication made from marijuana successfully reduced back pain in a new study, offering further support for the …
Source: pain medication
Karst is a pain specialist at Hannover Medical School and a consultant for Vertanical. For the new study, patients with back pain were randomly …
Source: back pain
